Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.
| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.34 | 2.65 | 3.29 | 3.98 | 4.40 | 6.26 | 8.11 | 9.62 | 10.59 | 11.10 |
| Growth | +13.0% | +24.1% | +21.0% | +10.6% | +42.1% | +29.6% | +18.6% | +10.1% | +4.9% | |
| Operating income | 0.42 | 0.46 | 0.71 | 0.89 | 0.82 | 1.33 | 1.33 | 2.13 | 2.51 | 2.21 |
| Net income | 0.30 | 0.26 | 0.48 | 0.65 | 0.59 | 0.98 | 0.85 | 1.55 | 1.81 | 1.58 |
| Growth | −14.7% | +87.0% | +33.4% | −8.8% | +65.6% | −12.4% | +81.4% | +17.1% | −13.0% | |
| EPS, diluted | 2.21 | 1.90 | 3.61 | 4.93 | 4.50 | 7.49 | 6.68 | 12.20 | 14.64 | 13.26 |
| Growth | −14.0% | +90.0% | +36.6% | −8.7% | +66.4% | −10.8% | +82.6% | +20.0% | −9.4% |
| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 51.2% | 52.8% | 55.2% | 55.9% | 56.0% | 57.7% | 55.4% | 58.3% | 59.2% | 56.6% |
| Operating margin | 18.0% | 17.2% | 21.5% | 22.3% | 18.6% | 21.3% | 16.4% | 22.2% | 23.7% | 19.9% |
| Net margin | 12.9% | 9.8% | 14.7% | 16.2% | 13.4% | 15.6% | 10.5% | 16.1% | 17.1% | 14.2% |
| Free cash flow margin | 10.1% | 12.5% | 15.7% | 9.7% | 13.0% | 15.9% | 4.0% | 17.1% | 15.0% | 8.3% |
| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.39 | 0.49 | 0.74 | 0.67 | 0.80 | 1.39 | 0.97 | 2.30 | 2.27 | 1.60 |
| Capital expenditure | −0.15 | −0.16 | −0.23 | −0.28 | −0.23 | −0.39 | −0.64 | −0.65 | −0.69 | −0.68 |
| Free cash flow | 0.24 | 0.33 | 0.52 | 0.39 | 0.57 | 0.99 | 0.33 | 1.64 | 1.58 | 0.92 |
| Growth | +39.9% | +56.0% | −25.3% | +48.6% | +73.2% | −67.0% | +401.6% | −3.7% | −41.8% | |
| Buybacks | −0.03 | −0.10 | −0.60 | −0.17 | −0.06 | −0.81 | −0.44 | −0.56 | −1.64 | −1.18 |
| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | 0.73 | 0.99 | 0.88 | 1.09 | 1.15 | 1.26 | 1.15 | 2.24 | 1.98 | 1.81 |
| Shareholders’ equity | 1.36 | 1.60 | 1.45 | 1.95 | 2.56 | 2.74 | 3.15 | 4.23 | 4.32 | 4.96 |
In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.
| Fiscal year | FY2017 29 Jan 2017 | FY2018 28 Jan 2018 | FY2019 3 Feb 2019 | FY2020 2 Feb 2020 | FY2021 31 Jan 2021 | FY2022 30 Jan 2022 | FY2023 29 Jan 2023 | FY2024 28 Jan 2024 | FY2025 2 Feb 2025 | FY2026 1 Feb 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operations | ||||||||||
| 0.39 | 0.49 | 0.74 | 0.67 | 0.80 | 1.39 | 0.97 | 2.30 | 2.27 | 1.60 | |
| Growth | +26.6% | +51.8% | −9.9% | +20.0% | +72.9% | −30.4% | +137.6% | −1.0% | −29.5% | |
| 0.09 | 0.11 | 0.12 | 0.16 | 0.19 | 0.22 | 0.29 | 0.38 | 0.45 | 0.50 | |
| Investment | ||||||||||
| −0.15 | −0.16 | −0.23 | −0.28 | −0.23 | −0.39 | −0.64 | −0.65 | −0.69 | −0.68 | |
| calc | 0.24 | 0.33 | 0.52 | 0.39 | 0.57 | 0.99 | 0.33 | 1.64 | 1.58 | 0.92 |
| Growth | +39.9% | +56.0% | −25.3% | +48.6% | +73.2% | −67.0% | +401.6% | −3.7% | −41.8% | |
| calc | 1.73 | 2.43 | 3.86 | 2.95 | 4.39 | 7.63 | 2.56 | 12.94 | 12.78 | 7.74 |
| −0.15 | −0.17 | −0.24 | −0.28 | −0.70 | −0.43 | −0.57 | −0.65 | −0.80 | −0.66 | |
| Financing | ||||||||||
| −0.03 | −0.10 | −0.59 | −0.18 | −0.08 | −0.84 | −0.47 | −0.55 | −1.65 | −1.21 | |
| −0.03 | −0.10 | −0.60 | −0.17 | −0.06 | −0.81 | −0.44 | −0.56 | −1.64 | −1.18 | |
Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.